Guangdong Hybribio Biotech Co (SZSE:300639) 3-Year Revenue Growth Rate : -3.80% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Guangdong Hybribio Biotech Co 3-Year Revenue Growth Rate?

Guangdong Hybribio Biotech Co's Revenue per Share for the three months ended in Mar. 2024 was ¥0.26.

During the past 12 months, Guangdong Hybribio Biotech Co's average Revenue per Share Growth Rate was -79.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was -3.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 33.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 25.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 12 years, the highest 3-Year average Revenue per Share Growth Rate of Guangdong Hybribio Biotech Co was 90.40% per year. The lowest was -3.80% per year. And the median was 24.40% per year.

Competitive Comparison of Guangdong Hybribio Biotech Co's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, Guangdong Hybribio Biotech Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guangdong Hybribio Biotech Co's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guangdong Hybribio Biotech Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Guangdong Hybribio Biotech Co's 3-Year Revenue Growth Rate falls into.

Guangdong Hybribio Biotech Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Guangdong Hybribio Biotech Co (SZSE:300639) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Guangdong Hybribio Biotech Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Guangdong Hybribio Biotech Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangdong Hybribio Biotech Co (SZSE:300639) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guangdong Hybribio Biotech Co Ltd (SZSE:300639) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

D 5-3-3-4, North High-tech Zone, Economic Development Zone, Chaozhou City, CHN, 521000

Website

http://www.hybribio.cn

Guangdong Hybribio Biotech Co Ltd is a Chinese company engaged in offering vitro diagnostic assays. Its products include in-vitro diagnostic kits, female sample collection kit, DNA extraction kit, and other devices. The company's products help in the infectious pathogens detection and genetic disease detection, including human papillomavirus, thalassemia, G6PD, hearing loss susceptibility, phenylketonuria, and early cancer detection, among others. The company has a business presence in China and various other countries.

Guangdong Hybribio Biotech Co (SZSE:300639) Headlines

No Headlines